Ignite Creation Date:
2024-05-06 @ 8:21 PM
Last Modification Date:
2024-10-26 @ 3:25 PM
Study NCT ID:
NCT06347198
Status:
RECRUITING
Last Update Posted:
2024-04-04
First Post:
2024-03-07
Brief Title:
Oral Inulin in Combination With Fruquintinib Plus Sintilimab as Third- or Further-line Treatment in Metastatic Colorectal Cancer
Sponsor:
Wuhan Union Hospital China
Organization:
Wuhan Union Hospital China
Organization Data
Organization:
Wuhan Union Hospital China
Class:
OTHER
Study ID:
20230807-02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Wuhan Union Hospital China
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Huazhong University of Science and Technology | OTHER |